Table 3.
Outcome | Characteristic | Model 1 HR (95% CI) |
Model 2 HR (95% CI) |
Model 3 HR (95% CI) |
Interaction term p-value |
---|---|---|---|---|---|
Any death (n=454) | Immune marker z-score | 1.09 (1.06–1.12) | 1.08 (1.05–1.12) | 1.08 (1.05–1.11) | 0.17 |
≥50% ICAS* | 2.10 (1.54–2.85) | 1.52 (1.12–2.07) | 1.47 (1.08–2.01) | ||
Vascular death (n=200) | Immune marker z-score | 1.11 (1.07–1.15) | 1.12 (1.07–1.16) | 1.11 (1.06–1.16) | 0.33 |
≥50% ICAS* | 2.95 (1.95–4.45) | 2.06 (1.36–3.13) | 1.94 (1.27–2.95) | ||
Any vascular event (n=324) | Immune marker z-score | 1.07 (1.04–1.11) | 1.06 (1.02–1.10) | 1.05 (1.01–1.09) | 0.72 |
≥50% ICAS* | 1.86 (1.29–2.69) | 1.39 (0.96–2.02) | 1.33 (0.91–1.93) |
HR = hazard ratio; CI = confidence interval; ICAS = intracranial larger artery stenosis
Reference not ≥50% ICAS.
Model 1 includes only immune marker z-score and ICAS.
Model 2 additionally includes age, sex, race, ethnicity.
Model 3 additionally includes hypertension, hyperlipidemia, diabetes mellitus, and smoking history.